The project has been designed for the collection of outcome and safety data on the use of novel interventional pharmacotherapy approaches. The AIPPAP Research Registry is designed to capture real-world clinical data on the use of ketamine, MDMA, and psilocybin.

This project aims to analyze the circulating miRNA pre-operation of the TKA and knee tissue mRNA post primary TKA.

Bacterial resistance to antibiotics is one of the most serious challenges to global public health, as drug resistance has been found for all classes of antibiotics used in clinical practice.

This project aims to improve understanding of the relationship between emotions and heart health and investigate the ability of emotion regulation interventions to improve cardiac functioning and recovery.

This team is undertaking various projects aiming to identify how exposure to enivronmental stress, including extreme heat exposure, can effect health and modify physiological, behavioural, perceptual and cognitive function.

The project will test the biocompatibility of the novel alloy and assess local tissue reaction and fracture healing at the test site as well as systemic absorption of metabolites.

The foundation of this research is a systematic review of the current literature and a conclusive definition of arrhythmogenic substrates in patients with nonischaemic mixed CMP.

This research aims to evaluate the efficacy of personalised transcranial alternating current stimulation (tACS) as a therapeutic approach for Major Depressive Disorder (MDD).

This project aims to investigate the effectiveness of transcranial alternating current stimulation (tACS) therapy in alleviating symptoms of Obsessive-Compulsive Disorder (OCD).

This research aims to explore various transcranial alternating current stimulation (tACS) methods to identify the most effective procedure for modulating brain activity to enhance memory and mood.

We are currently developing a set of materials that show high potential in facilitating and enhancing cellular growth and tissue regeneration using biochemical technology and 3D printing technology.

This program will provide better understanding of mRNA related to aberrantly expressed miRNAs, which would be drug targets.

The Registry has been designed to collect data over a long follow-up period to try to understand the outcomes of patients receiving multiple rounds of TMS and brain stimulation treatments.

This research looks at the effects that ageing has on driving abilities and applied cognition and will develop tools to determine if a person is a safe driver in order to ensure road safety.